Predictors of smoking reduction among Blacks
- PMID: 20194521
- PMCID: PMC2847079
- DOI: 10.1093/ntr/ntq019
Predictors of smoking reduction among Blacks
Abstract
Introduction: Blacks who smoke have increased tobacco-related health risks. Cessation decreases the likelihood of many health problems. Smoking reduction may be important in the cessation process and potentially reduce health risks.
Methods: Because little is known about specific predictors of smoking reduction, we investigated factors predicting reduction among Black light smokers enrolled in a 26-week cessation trial. Specifically, we compared (a) reducers (reduced cigarettes per day [cpd] >or=50%) with nonreducers and (b) reducers with quitters. Baseline demographic, smoking-related, and psychosocial variables were collected, and Week 26 smoking status was assessed.
Results: Among 539 participants, 41.0% (n = 221) reduced their smoking, 17.6% (n = 95) quit, and 41.4% (n = 223) did not reduce their smoking by >or=50%. In comparison with reducers, nonreducers were more likely to have their first cigarette within 30 min of waking (odds ratio [OR] = 2.4, 95% CI = 1.47-3.93), lower baseline cpd (OR = 0.84, 95% CI = 0.77-0.93), higher baseline cotinine levels (OR = 1.002, 95% CI = 1.000-1.003), lower perceived stress (OR = 0.86, 95% CI = 0.78-0.95), and higher Smoking Consequences Questionnaire (SCQ) negative social impression scores (OR = 1.04, 95% CI = 1.01-1.06), after controlling for treatment arm, gender, and age. Significant predictors of smoking cessation versus reduction included lower baseline cpd (OR = 0.85, 95% CI = 0.75-0.95), higher nicotine dependence (OR = 1.47, 95% CI = 1.09-1.98), lower baseline cotinine levels (OR = 0.996, 95% CI = 0.994-0.998), higher body mass index (OR = 1.05, 95% CI = 1.01-1.08), lower perceived stress (OR = 0.82, 95% CI = 0.72-0.95), and higher SCQ negative social impression scores (OR = 1.05, 95% CI = 1.01-1.08).
Discussion: Distinct predictors are associated with different trajectories of smoking behavior change (i.e., reduction vs. cessation vs. no change).
References
-
- Ahijevych K, Garrett BE. Menthol pharmacology and its potential impact on cigarette smoking behavior. Nicotine and Tobacco Research. 2004;6(Suppl. 1):S17–S28. - PubMed
-
- Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in Black and White women. Pharmacology, Biochemistry, and Behavior. 1996;53:355–360. - PubMed
-
- Ahluwalia J, Okuyemi K, Nollen N, Choi W, Kaur H, Pulvers K, et al. The effects of nicotine gum and counseling among African American light smokers: A 2 × 2 factorial design. Addiction. 2006;101:883–891. - PubMed
-
- Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Review. 1996;18:188–204. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
